| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models
|
Kannan, Sankaranarayanan
|
|
|
9 |
3 |
p. 473-487
|
article
|
| 2 |
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma
|
Looka, Andrew
|
|
|
9 |
3 |
p. 455-462
|
article
|
| 3 |
A telemedicine triage model for infusion center–based management of adult sickle cell pain episodes
|
Bliamptis, John
|
|
|
9 |
3 |
p. 603-605
|
article
|
| 4 |
Caregiver signaling questions in sickle cell disease
|
Schatz, Jeffrey
|
|
|
9 |
3 |
p. 658-659
|
article
|
| 5 |
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma
|
Zugasti, Inés
|
|
|
9 |
3 |
p. 571-582
|
article
|
| 6 |
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
|
Fattizzo, Bruno
|
|
|
9 |
3 |
p. 488-495
|
article
|
| 7 |
Congenital T-cell activation impairs transitional-to-follicular B-cell maturation in humans
|
Allard-Chamard, Hugues
|
|
|
9 |
3 |
p. 520-532
|
article
|
| 8 |
Development and validation of predictive models of early immune effector cell–associated hematotoxicity
|
Liang, Emily C.
|
|
|
9 |
3 |
p. 606-616
|
article
|
| 9 |
Diagnosis of TP53-mutated myeloid disease by the ICC and WHO fifth edition classifications
|
Hart, Stephanie A.
|
|
|
9 |
3 |
p. 445-454
|
article
|
| 10 |
Evolving racial/ethnic disparities in AML survival in the novel therapy era
|
Wang, Xin
|
|
|
9 |
3 |
p. 533-544
|
article
|
| 11 |
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells
|
Battram, Anthony M.
|
|
|
9 |
3 |
p. 627-641
|
article
|
| 12 |
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
|
Han, Jessy Xinyi
|
|
|
9 |
3 |
p. 583-602
|
article
|
| 13 |
IDCH: is it now determined?
|
Gulati, Nitya
|
|
|
9 |
3 |
p. 496-498
|
article
|
| 14 |
Loss of protein C vs protein S results in discrepant thrombotic phenotypes
|
Ku, Chia-Jui
|
|
|
9 |
3 |
p. 545-557
|
article
|
| 15 |
Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
|
Ali, Naveed
|
|
|
9 |
3 |
p. 558-570
|
article
|
| 16 |
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
|
Bhutani, Manisha
|
|
|
9 |
3 |
p. 507-519
|
article
|
| 17 |
PETAL: a global view on R/R T-/NK-lymphoma treatment reality
|
Jiang, Qu
|
|
|
9 |
3 |
p. 642-643
|
article
|
| 18 |
PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma
|
Douglas, Genevieve
|
|
|
9 |
3 |
p. 499-506
|
article
|
| 19 |
PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation
|
Desai, Nihar
|
|
|
9 |
3 |
p. 660-669
|
article
|
| 20 |
PTCy unchained in matched siblings: the D is silent in GVHD
|
Gagelmann, Nico
|
|
|
9 |
3 |
p. 670-671
|
article
|
| 21 |
Racial and socioeconomic status diversity and GVHD outcomes
|
Farhadfar, Nosha
|
|
|
9 |
3 |
p. 644
|
article
|
| 22 |
RAPID-CRISPR: highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia
|
Maity, Akash
|
|
|
9 |
3 |
p. 463-472
|
article
|
| 23 |
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
|
Kemps, Paul G.
|
|
|
9 |
3 |
p. 439-444
|
article
|
| 24 |
Utility of caregiver signaling questions to detect neurocognitive impairment in children with sickle cell disease
|
Dandar, Christina M.
|
|
|
9 |
3 |
p. 645-657
|
article
|
| 25 |
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
|
Luskin, Marlise R.
|
|
|
9 |
3 |
p. 617-626
|
article
|
Journal description